Date: May 11, 2017
Location: New York, NY
- Coordinating 21st Century Cures with The Trump Administration FDA Priorities
The 21st Century Cures Act was a major bipartisan legislation that requires significant rulemaking and guidance activity by FDA in 2017. However, the Trump Administration policies for reduced regulatory burden and FDA priorities do not align entirely with the statutory directives. This session will dive deep into the progress made in implementing 21st Century Cures requirements and discuss the intersection with Trump’s FDA priorities.
Bethany J. Hills is recognized for her experience and insight on FDA matters. At Mintz, she advises health care providers on pre- and post-market issues. Bethany also helps international and US companies enter and navigate the US health care market.